Skip to main content Help with accessibility Skip to main navigation

Fremanezumab

Indication

Fremanezumab for preventing migraine (NICE TA764)

NICE TA764 - Fremanezumab for preventing migraine

Red

Brand:

Nice TA:

764

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:
Central nervous system

Background

1.1 Fremanezumab is recommended as an option for preventing migraine in adults, only if:

  • they have 4 or more migraine days a month

  • at least 3 preventive drug treatments have failed and

  • the company provides it according to the commercial arrangement.

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

Decisions of Lancashire local decision making groups

Red
Red
Red
Red
Red
Red
Red
Red
What do the colours mean?

Last Updated: 15 - Mar - 2022